A Japanese cohort study also found that anti-MDA5-positive idiopathic inflammatory myopathy (IIM) cases often progress to fulminant and fatal ILD, with an estimated 30–60% incidence and a six-fold increase in mortality risk compared to anti-MDA5-negative counterparts [41]. This evidence concerns the gene IFIH1 and idiopathic inflammatory myopathy.